Hypofractionated radiotherapy denoted as the "christie scheme": An effective means of palliating patients with head and neck cancers not suitable for curative treatment

Acta Oncologica

Volumn 48, Issue 4, 2009, Pages 562-570

  Al Mamgani, Abrahim ^a   Tans, Lisa ^a   Van Rooij, Peter H E ^a   Noever, Inge ^a   Baatenburg De Jong, Robert J ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; OVERALL SURVIVAL; PERFORMANCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE; FOLLOW UP; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PATHOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOTHERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 65549140790     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860902740899     Document Type: Article

References (19)

1. Steel GG. Basic clinical radiobiology. 3rd ed. New York: Hodder Arnold; 2002.
2. Paterson R. Studies in optimum dosage. Br J Radiol 1952;/ 25:/505-16.
3. Schofield CP, Sykes AJ, Slevin NJ, Rashid NZZ. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 2003;/69:/37-42.
4. Weissberg JB, Son YH, Percarpio B, Fischer JJ. Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1982;/8:/179-85.
5. Corry JF, Peters LJ, D'Costa I, Milner AD, Fawns H, Rischin D, et al. The "Quad Shot" a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2006;/77:/137-42.
6. Henk JM, James KW. A comparative trial of large and small fractions. Br J Radiol 1976;/49:/1055-6.
7. Porceddu SV, Rosser B, Burmeister BH, Jones M, Hickey B, Baumann K, et al. Hypofractionated radiotherapy for the palliation of advanced head and neck unsuitable for curative treatment "Hypo Trial". Radiother Oncol 2007;/85:/ 456-62.
8. Wierink G, Alcock CJ, Bated TD, Brindle JM, Fowler JF, Gajek WR, et al. Final report on the second British Institute of Radiology fractionation study: Short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx. Br J Radiol 1991;/64:/232.
9. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: The Christie and Royal Marsden Hospital experience. Radiother Oncol 2003;/68:/105-11.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and European Organisation for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;/31:/1341-6.
11. Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000;36:1796-807.
12. Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer 2000;/36:/1032-7.
13. Laskar SG, Agarwal JP, Srinivas C, Dinshaw KA. Radiotherapeutic management of locally advanced head and neck cancer. Expert Rev Anticancer Ther 2006;/6:/405-17.
14. Bonner JA, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Eng J Med 2006;/354:/ 567-78.
15. Levendag PC, Nowak PJ, van der Sangen MJ, Jansen PP, Eijkenboom WM, Planting AS, et al. Local tumor control in radiation therapy of cancers in the head and neck. Am J Clin Oncol 1996;/19:/469-77.
16. Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck 2001;/9:/718-24. (Pubitemid 32751487)
17. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NP. Radiotherapy for squamous cell carcinoma supraglottic larynx: An alternative to surgery. Head Neck 1996;/18:/24-35.
18. Mendenhall WM, Parson JT, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation: Relationship of dose-fractionation factors for local control and complications. Int J Radiat Oncol Biol Phys 1988;/15:/1267-73.
19. Ensley JF, Jacobs JR, Weaver A, Kinzie J, Crissman J, Kish JA. Correlation between response to cisplatinumcombination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984;/54:/811-4.